Summary:
Bakersfield Dermatology and Skin Cancer Medical Group is conducting an open-label, multi-center, 52-week, long-term study to evaluate the safety and efficacy of 50 ug/g m518101 in subjects with Plaque Psoriasis.
Qualified Participants Must:
• Be 18 years of age or older
•
Have moderate to severe plaque psoriasis
•
Have psoriasis affecting up to 20% of your body
Qualified Participants May Receive:
Study related physical examinations, study drugs and limited compensation for time & travel related to study.